INTRODUCTION {#S1}
============

Nervous system wiring during development involves a carefully orchestrated sequence of events, including neuronal migration and axon extension. The migrating neuronal cell body is pulled by a leading process ([@R38]), but, once properly localized, the soma remains in place while the nascent axon projects to its target. Axons are guided by attractive and repulsive cues that activate receptors on their growth cones ([@R28]); pathfinding is further facilitated by fasciculation, mediated by axon-axon interactions via cell adhesion molecules (CAMs) or channeling via surround repulsion, as late-extending axons can rely on guidance decisions made by pioneer axons ([@R48]; [@R66]). Despite their central importance to neural circuit assembly, the cellular and molecular mechanisms that control and cross-coordinate neuronal migration, axon guidance, and axon fasciculation are not completely understood.

Motor neurons (MNs) in the hindbrain and spinal cord face unique challenges during wiring, as their cell bodies reside in the central nervous system (CNS), but their axons project into the body periphery. In the developing spinal cord, postmitotic MNs migrate from their birthplace in the ventricular zone to settle in the ventral horn. Motor axons subsequently leave the neural tube through motor exit points (MEPs) and fasciculate to form segmentally repeated ventral roots (VRs) ([Figure 1A](#F1){ref-type="fig"}) ([@R5]). Previous work indicates that MN cell bodies need to be actively prevented from following their axons into the periphery. For instance, ablation of VR-associated boundary cap cells or the repulsive cue Sema6A, which is expressed by these cells, results in MN emigration from the spinal cord ([@R6]; [@R44]; [@R63]). Additionally, radial glia endfeet have been implicated in sealing off MEPs from within, preventing MNs from exiting the neural tube ([@R33]). Still, the precise mechanisms that confine MN somata to the CNS while allowing motor axon exit remain largely unexplored.

Adding to the complexity of MN development, MNs are grossly segregated into motor columns, and distinct genetic programs endow these different MN populations with specific guidance receptor profiles, which direct their axons to various peripheral targets via series of successive choice points ([@R5]). At brachial level, the medial motor column (MMC) sends axons to epaxial muscles, and the lateral motor column (LMC) innervates the limb; the LMC is further partitioned into lateral (LMCl) and medial (LMCm) subdivisions, which send their axons into the dorsal and ventral halves of the limb bud, respectively ([@R5]; [@R57]). MMC and LMC axons initially co-extend in VRs but segregate just ventral to dorsal root ganglia (DRGs), where sensory axons join motor projections and follow them toward peripheral targets ([Figure 1A](#F1){ref-type="fig"}) ([@R4]; [@R57]; [@R67]). While previous work has identified multiple motor column-specific axon guidance mechanisms ([@R5]; [@R57]), the underpinnings of the diverse guidance decisions made by differentmotoraxon populations are still not completely understood.

Here, we identified transient axonal glycoprotein type-1 (TAG-1) as an essential regulator of MN containment within the spinal cord, motor axon fasciculation, and LMC axon guidance. TAG-1 is a glycosylphosphatidylinositol-linked CAM of the Contactin family that is transiently expressed by a variety of neuronal populations during neural circuit assembly ([@R25]; [@R40]; [@R71]; [@R73]). Previous *in vitro* experiments and limited genetic analysis *in vivo* have demonstrated that TAG-1 participates in homophilic interactions and binds multiple other CAMs to regulate axon growth, guidance, and fasciculation ([@R3]; [@R15]; [@R40]; [@R51]). Additionally, TAG-1 is an indirect mediator of repulsive Semaphorin signaling in DRG neurons, and positively regulates axonal response to other, as-yet-unidentified, diffusible repellants ([@R9]; [@R32]; [@R41], [@R42]). The now 33-year-old discovery that TAG-1 is transiently expressed by MNs during early stages of development suggested that it regulates MN wiring ([@R73]), but its function in MNs had since remained elusive.

Using a combination of mouse genetics, *in vivo* phenotype analysis, and *in vitro* assays, we demonstrate that TAG-1 plays an integral role in multiple aspects of MN development. In particular, TAG-1 expression by MNs anchors their cell bodies in the ventral horn, preventing their emigration from the spinal cord. Additionally, TAG-1 mediates axon-axon interactions essential for motor axon fasciculation within VRs, and it is required in MNs to guide LMC, but not MMC, axons past DRGs. These three functions of TAG-1 are independent from one another and appear to involve partially divergent molecular mechanisms. Our results identify TAG-1 as a key multifunctional regulator of MN wiring that controls both pan-MN and motor column-specific aspects of motor circuit assembly.

RESULTS {#S2}
=======

TAG-1 Is Transiently Expressed on Migrating Motor Neuron Cell Bodies and Localizes to Distal Motor Axons during Neurite Extension {#S3}
---------------------------------------------------------------------------------------------------------------------------------

In mice, TAG-1 was first reported to be expressed by spinal MNs and their axons exclusively at embryonic day 10.0 (E10.0), based on immunohistochemistry (IHC) using a monoclonal TAG-1 antibody ([@R73]). A new, polyclonal antibody against TAG-1 provides increased sensitivity ([@R72]), and we found that it strongly labels commissural axons, as well as DRG neurons and their axons; unlike the monoclonal antibody, it also labels spinal cord VRs of E11.5 wild-type, but not *TAG-1* mutant mice ([Figure S1A](#SD1){ref-type="supplementary-material"}), confirming its specificity and improved sensitivity. We used this antibody to reevaluate the time window of TAG-1 expression in developing MNs via IHC on transverse sections of mouse embryonic brachial spinal cord and limb bud ([Figure 1A](#F1){ref-type="fig"}). We found that TAG-1 is first expressed by newly differentiated MNs on their cell bodies and leading processes at E9.0 as they migrate from the ventricular zone to the presumptive ventral horn ([Figure 1B](#F1){ref-type="fig"}). At E9.5, when the first motor axons exit the spinal cord and begin to form VRs, TAG-1 continues to be expressed on all MN somata ([Figure 1C](#F1){ref-type="fig"}). Cell body expression becomes restricted to a subset of MNs at E10.5 and is abolished by E11.5 ([Figure 1C](#F1){ref-type="fig"}). We examined TAG-1 expression on E10.5 MN cell bodies more closely by co-labeling with antibodies against motor column-specific markers and found that subsets of brachial MMC, LMCl, and LMCm neurons are TAG-1-positive (TAG-1^+^) ([Figures 1D](#F1){ref-type="fig"} and [1E](#F1){ref-type="fig"}), indicating that gradual loss of TAG-1 is not restricted to any particular motor column(s). Broad expression of TAG-1 across the entire MN population was also observed in cervical, thoracic, and lumbar E10.5 spinal cord, as well as in the hindbrain (Figure S1B; data not shown). When we examined TAG-1 expression on motor axons, we found that TAG-1 is present on all VR axons at E9.5 and E10.5, expressed on a subset at E11.5, and lost from VRs by E12.5 ([Figure 1C](#F1){ref-type="fig"}). However, TAG-1 IHC on limb buds of E12.5 embryos carrying the MN-specific *HB9::GFP* transgene revealed that distal motor axons still express TAG-1 ([Figure 1F](#F1){ref-type="fig"}). Together, these data demonstrate that TAG-1 is transiently present on MN cell bodies as they migrate and settle in the ventral horn, and that it localizes to the distal segment of motor axons as they exit the neural tube through VRs and extend into the body periphery.

TAG-1 Prevents Motor Neuron Emigration from the Spinal Cord {#S4}
-----------------------------------------------------------

The early expression of TAG-1 on MN somata is consistent with the idea that it regulates MN positioning. To test this possibility, we examined MN cell bodies in mice lacking TAG-1 ([@R46]) by IHC. We found that, at brachial level, a subset (≈3.5%) of MNs fail to be contained within the spinal cord in E11.5 *TAG-1^−/−^* embryos; these MNs are instead aberrantly positioned outside of the neural tube within motor axon tracts ([Figure 2A](#F2){ref-type="fig"}). In some cases, MNs have migrated more than 550 μm away from the MEP, e.g., into the limb plexus (data not shown). Ectopic MNs are not observed in *TAG-1^−/−^* embryos ([Figure 2B](#F2){ref-type="fig"}), even though TAG-1 protein levels in these heterozygous animals are reduced by about 50% compared to wild type ([Figures S1C](#SD1){ref-type="supplementary-material"} and [S1D](#SD1){ref-type="supplementary-material"}). Time course analysis revealed that MNs in *TAG-1^−/−^* embryos are normally positioned within the ventral horn at E9.5, have migrated out of the spinal cord at E10.5, and persist in the periphery through at least E13.5 ([Figure 2C](#F2){ref-type="fig"}); however, no ectopic MNs are present at postnatal day 0 (P0), suggesting that these mispositioned neurons are eliminated over time (data not shown). We found that, at brachial level, MNs belonging to all motor columns (MMC, LMCl, and LMCm) emigrate from the *TAG-1^−/−^* spinal cord ([Figures 2D](#F2){ref-type="fig"} and [2E](#F2){ref-type="fig"}). Compared to wild type, the total number of MNs within the brachial *TAG-1^−/−^* spinal cord is slightly but not significantly decreased across all motor columns ([Figure 2F](#F2){ref-type="fig"}). When we examined MN positioning in E11.5 wild-type and *TAG-1^−/−^* mice at hindbrain, cervical, thoracic, and lumbar levels, we consistently observed a significant increase in ectopic MNs in *TAG-1* mutant mice ([Figure S2A](#SD1){ref-type="supplementary-material"}). In the spinal cord, this defect arises predominately from the emigration of non-MMC MNs; MMC MN emigration is significantly increased at brachial level, appears elevated at cervical and lumbar levels without reaching statistical significance, and does not appear to be a driver of the phenotype at thoracic level ([Figure S2A](#SD1){ref-type="supplementary-material"}). Overall motor column segregation appears normal in *TAG-1* mutant mice, except adjacent to MEPs where MMC and LMC neurons intermingle on their way out of the spinal cord ([Figures S2B](#SD1){ref-type="supplementary-material"} and [S2C](#SD1){ref-type="supplementary-material"}). Thus, TAG-1 is required to prevent MNs from exiting the spinal cord, irrespective of motor column identity and without controlling motor column organization.

TAG-1 Expression by Motor Neurons Anchors Them within the Spinal Cord {#S5}
---------------------------------------------------------------------

Previous work suggests that radial glia endfeet at MEPs prevent MN emigration from the ventral horn ([@R33]). Additionally, MEP-associated boundary cap cells are required to contain MNs within the spinal cord ([@R6]; [@R44]; [@R63]). Hence, we addressed the possibility that MNs leave the spinal cord in *TAG-1* mutant mice due to defects in the organization of these cell types. Using IHC, we observed normal morphology of radial glia and their endfeet in tight association with MEPs in E11.5 *TAG-1* embryos ([Figure S2D](#SD1){ref-type="supplementary-material"}). We also examined the localization of boundary cap cells via *in situ* hybridization for *Krox20*, which labels these cells ([@R54]; [@R70]). We found that boundary cap cells are associated with VRs at MEPs in *TAG-1^−/−^; HB9::GFP* embryos, just as in *HB9::GFP* control littermates ([Figures S2E](#SD1){ref-type="supplementary-material"} and [S2F](#SD1){ref-type="supplementary-material"}), and their number per VR does not differ between these two genotypes (*HB9::GFP*, 18.20 ± 1.934; *TAG-1^−/−^; HB9::GFP*, 18.75 ± 0.6439; p = 0.7058; n = 3 embryos per genotype). Collectively, these results indicate that ectopic MN migration in *TAG-1^−/−^* mice is not a consequence of defects in radial glia endfeet organization or boundary cap cell clustering at MEPs.

To determine whether TAG-1 is required cell autonomously in MNs to prevent their exit from the spinal cord, we generated a *TAG-1* conditional knockout allele (*TAG-1^cKO^*) ([Figures S3A](#SD1){ref-type="supplementary-material"} and [S3B](#SD1){ref-type="supplementary-material"}). We first validated this allele by deleting *TAG-1* in the germline using E2A::Cre mice ([@R30]). Mice homozygous for the Cre-deleted version of the conditional allele (*TAG-1^Δ^*) exhibited a dramatic reduction or complete loss of TAG-1 protein, as determined by IHC ([Figures S3C](#SD1){ref-type="supplementary-material"} and [S3D](#SD1){ref-type="supplementary-material"}) or western blot ([Figures S3E](#SD1){ref-type="supplementary-material"} and [S3F](#SD1){ref-type="supplementary-material"}), respectively, indicating that the allele is null or near null upon Cre-mediated deletion. For MN-specific Cre expression, we used *Olig2^Cre^* mice ([@R10]). By crossing to a *ROSA26^LSL-tdTom^* reporter line that expresses tdTomato in a Cre-dependent manner ([@R37]), we confirmed that, as early as E9.5, *Olig2^Cre^* drives Cre activity in 100% of MNs ([Figures S4A](#SD1){ref-type="supplementary-material"} and [S4B](#SD1){ref-type="supplementary-material"}). We then generated *Olig2^Cre/+^; TAG-1^cKO/cKO^* mice to delete *TAG-1* in MNs. Using IHC, we found that TAG-1 protein is lost from MNs and VRs in *Olig2^Cre/+^; TAG-1^cKO/cKO^* embryos, but not *TAG-1^cKO/cKO^* littermates, at both E9.5 ([Figures S4C](#SD1){ref-type="supplementary-material"} and [S4D](#SD1){ref-type="supplementary-material"}) and E11.5, while commissural axons and DRG neurons/axons retain normal TAG-1 levels ([Figures S3G](#SD1){ref-type="supplementary-material"} and [S3H](#SD1){ref-type="supplementary-material"}). Thus, TAG-1 is selectively and efficiently ablated from developing MNs in *Olig2^Cre/+^; TAG-1^cKO/cKO^* mice. When we assessed MN positioning in *Olig2^Cre/+^; TAG-1^cKO/cKO^; HB9::GFP* mice, we observed ectopic MNs outside of the spinal cord, with the severity of this phenotype being indistinguishable from the complete *TAG-1* knockout ([Figures 3A](#F3){ref-type="fig"} and [3B](#F3){ref-type="fig"}; compare to [Figure 2B](#F2){ref-type="fig"}). These data indicate that TAG-1 is specifically required in MNs to prevent their emigration from the neural tube.

We also deleted *TAG-1* using a different Cre-expressing line, *Olig2^IRES-Cre^* ([@R75]), which results in stochastic Cre-mediated recombination in about 40% (39.17 ± 0.33%; n = 3 embryos) of MNs ([Figures S4E](#SD1){ref-type="supplementary-material"} and [S4F](#SD1){ref-type="supplementary-material"}), and found that ectopic MN migration does not occur in *Olig2^IRES-Cre/+^; TAG-1^cKO/cKO^; HB9::GFP* embryos (data not shown). Thus, expression of TAG-1 in the majority (≈60%) of MNs can compensate for loss of TAG-1 from individual MNs and prevent their exit from the spinal cord, suggesting that TAG-1 does not act strictly cell autonomously in MN migration.

Boundary cap cell-derived Sema6A has been implicated as a repulsive signal that confines MN cell bodies to the spinal cord via Neuropilin-2 (Nrp2) ([@R6]). Because TAG-1 can positively regulate Semaphorin signaling ([@R9]; [@R32]), we investigated the possibility that TAG-1 prevents MN emigration from the spinal cord via the Sema6A-Nrp2 pathway. We analyzed E11.5 *Sema6A^−/−^* mice and found that MNs exit the spinal cord at both forelimb and hindlimb level; however, at the brachial level, this phenotype is less severe than in *TAG-1* mutants ([Figures S5A](#SD1){ref-type="supplementary-material"} and [S5B](#SD1){ref-type="supplementary-material"}; compare to [Figure 2B](#F2){ref-type="fig"}), and it is more pronounced at the lumbar level ([Figures S5A](#SD1){ref-type="supplementary-material"} and [S5C](#SD1){ref-type="supplementary-material"}), unlike the *TAG-1* knockout ([Figure S2A](#SD1){ref-type="supplementary-material"}). Furthermore, when we deleted *Nrp2* in MNs of *Olig2^Cre/+^; Nrp2^cKO/cKO^; HB9::GFP* mice, we observed no increase in MN emigration compared to littermate controls ([Figures S5D](#SD1){ref-type="supplementary-material"}--[S5F](#SD1){ref-type="supplementary-material"}). Together, these results argue against disrupted Sema6A signaling as main driver of MN emigration in mice lacking TAG-1.

Previous work supports the idea that TAG-1 is required for responsiveness to repulsive guidance molecules other than Semaphorins ([@R32]; [@R41], [@R42], [@R43]), leaving open the possibility that MN emigration in *TAG-1^−/−^* mice is caused by loss of MN repulsion from other cues in the spinal cord periphery. To test this idea, we studied MN migration in cultures of spinal cord ventral horn explants, which eliminates interactions with tissues outside the neural tube. Cultured E11.5 MNs express TAG-1 on their cell bodies and axons ([Figure S6A](#SD1){ref-type="supplementary-material"}), allowing investigation of TAG-1 function *in vitro*. When we cultured ventral spinal cord explants from E11.5 *HB9::GFP* and *TAG-1^−/−^; HB9::GFP* embryos, we found that an increased number of MN cell bodies migrate out of explants from mice lacking TAG-1 compared to littermate control explants ([Figures 3C](#F3){ref-type="fig"}, [3D](#F3){ref-type="fig"}, and [S6B](#SD1){ref-type="supplementary-material"}). This demonstrates that TAG-1 prevents MN emigration from the ventral horn through spinal cord-intrinsic mechanisms, not via interactions with the spinal cord periphery.

To determine whether TAG-1 activates a signal that restricts MN migration or instead anchors MNs in the spinal cord by mediating adhesion, we cultured ventral spinal cord explants on a substrate containing recombinant TAG-1. We found that MN emigration from *HB9::GFP* explants is drastically increased on TAG-1 compared to control substrate ([Figures 3E](#F3){ref-type="fig"} and [3F](#F3){ref-type="fig"}), indicating that ectopic TAG-1 can compete with endogenous TAG-1 as an adhesive substrate for MNs. In contrast, MNs from *TAG-1^−/−^; HB9::GFP* explants do not exhibit increased migration on a TAG-1 substrate, and their rate of migration is below that of *HB9::GFP* MNs cultured on TAG-1 ([Figures 3E](#F3){ref-type="fig"} and [3F](#F3){ref-type="fig"}). This result demonstrates that MN-derived TAG-1 is required for the pro-migratory effect of ectopic TAG-1. Together, these findings support the idea that TAG-1 expression on MNs anchors them within the spinal cord by mediating homophilic adhesion.

TAG-1 Controls Ventral Root Thickness {#S6}
-------------------------------------

Expression of TAG-1 in spinal cord VRs suggests that it controls motor axon behavior during exit from the neural tube. To test this idea, we examined VRs in E11.5 *TAG-1^−/−^; HB9::GFP* embryos. We found that VRs are expanded in mice lacking TAG-1 ([Figure 4A](#F4){ref-type="fig"}), resulting in a nearly 50% increase in root diameter compared to *TAG-1* heterozygous and wild-type littermates ([Figure 4B](#F4){ref-type="fig"}). Time course analysis of this phenotype in whole, optically cleared embryos ([Figure S7A](#SD1){ref-type="supplementary-material"}) revealed that VR diameter in *TAG-1^−/−^* embryos is already increased at E9.5 and remains elevated through E12.5; at E13.5, wild-type roots reach the same size as in *TAG-1* knockout mice ([Figure 4C](#F4){ref-type="fig"}). VRs are also expanded in the rostro-caudal dimension and frequently fail to completely separate from one another in E11.5 *TAG-1^−/−^* embryos; the magnitude of this effect is similarly diminished by E13.5 ([Figures S7B](#SD1){ref-type="supplementary-material"} and [S7C](#SD1){ref-type="supplementary-material"}). We observed no correlation between VR diameter and the number of ectopic MNs per root in *TAG-1^−/−^* mice ([Figure 4D](#F4){ref-type="fig"}). Combined with the fact that VR expansion in *TAG-1* mutants is detectable a full day before presence of ectopic MNs, this argues against root expansion being a secondary consequence of MN emigration. Thus, TAG-1 negatively regulates VR size, independent from its function in containing MN cell bodies within the spinal cord.

Motor Neuron-Derived TAG-1 Promotes Motor Axon Fasciculation Independent of Interactions with Peripheral Tissues {#S7}
----------------------------------------------------------------------------------------------------------------

TAG-1 can promote axon fasciculation in multiple neuronal populations ([@R7]; [@R41]; [@R51]; [@R58]; [@R59]). However, we first considered the possibility that VR expansion in *TAG-1^−/−^* mice does not result from motor axon defasciculation and tested two alternative hypotheses---that an increased number of Schwann cells or presence of additional axons within VRs cause the observed phenotype. Using IHC for the neural crest marker Sox10, we found comparable numbers of Schwann cell precursors in VRs of E11.5 wild-type and *TAG-1^−/−^* embryos ([Figures S8A](#SD1){ref-type="supplementary-material"} and [S8B](#SD1){ref-type="supplementary-material"}). MNs are generated in equal numbers in wild-type and *TAG-1^−/−^* embryos ([Figures S8C](#SD1){ref-type="supplementary-material"}, [S8D](#SD1){ref-type="supplementary-material"}, and [2F](#SD1){ref-type="supplementary-material"}), arguing against the presence of additional motor axons in *TAG-1^−/−^* VRs. To determine whether neuronal populations other than MNs aberrantly project axons into *TAG-1^−/−^* VRs, we conducted DiI tracing experiments ([Figure S8E](#SD1){ref-type="supplementary-material"}). Anterograde tracing from dorsal spinal cord labeled contralaterally and ipsilaterally projecting axons and showed that neither of these axonal populations project into VRs ([Figure S8F](#SD1){ref-type="supplementary-material"}) of *TAG-1^−/−^* and wild-type embryos. Conversely, retrograde tracing from VRs exclusively labeled neurons in the portion of the ventral horn occupied by MNs ([Figure S8G](#SD1){ref-type="supplementary-material"}). Taken together, these data suggest that neither excess Schwann cells nor extraneous axons cause VR expansion in mice lacking TAG-1; rather, they support the idea that the phenotype reflects a requirement for TAG-1 in motor axon fasciculation.

To determine whether TAG-1 is required in MNs to control VR size, we analyzed E11.5 *Olig2^Cre/+^; TAG-1^cKO/cKO^; HB9::GFP* embryos. We found that root diameter is increased by about 50% ([Figures 5A](#F5){ref-type="fig"} and [5B](#F5){ref-type="fig"}), and rostro-caudal VR separation is impaired ([Figure S7D](#SD1){ref-type="supplementary-material"}), similar to the complete *TAG-1* knockout. Stochastic deletion of *TAG-1* using *Olig2^IRES-Cre^* causes a slight (≈13%) increase in VR diameter (at E11.5, *TAG-1^cKO/cKO^; HB9::GFP*, 26.36 ± 0.95 μm; *Olig2^IRES-Cre/+^; TAG-1^cKO/cKO^; HB9::GFP*, 30.11 ± 0.77 μm; p = 0.022; n = 4 embryos per genotype). These data indicate that TAG-1 acts cell-autonomously in MNs to regulate VR size.

To investigate whether TAG-1 controls motor axon fasciculation, we examined axon growth from ventral spinal cord explants *in vitro*. We found that motor axons emerge from E11.5 *HB9::GFP* explants as a mix of individual axons and fascicles of various sizes, while *TAG-1^−/−^; HB9::GFP* motor axons form fewer thick bundles and remain less fasciculated ([Figures 5C](#F5){ref-type="fig"} and [5D](#F5){ref-type="fig"}). Thus, TAG-1 expression by MNs promotes motor axon fasciculation, and this function does not require interactions with tissues outside of the spinal cord.

To distinguish between a signaling and an adhesion mechanism for TAG-1's function in motor axon fasciculation, we cultured ventral spinal cord explants on a TAG-1 substrate. We found that fasciculation of axons from *HB9::GFP* explants is slightly impaired on a TAG-1-coated surface compared to control ([Figures 5E](#F5){ref-type="fig"} and [5F](#F5){ref-type="fig"}), indicating that ectopic TAG-1 competes with axonal TAG-1 as the preferred substrate for motor axon growth. Substrate-bound TAG-1 did not affect axon fasciculation from *TAG-1^−/−^; HB9::GFP* explants (data not shown), indicating that endogenous TAG-1 on motor axons is required for the adhesive effect of ectopic TAG-1. Together, these results suggest that TAG-1 homophilic binding mediates axon-axon adhesion to promote motor axon fasciculation.

TAG-1 Prevents LMC Motor Axons from Invading DRGs {#S8}
-------------------------------------------------

TAG-1 is expressed on motor axons as they navigate to their targets in the periphery, raising the possibility that it controls motor axon guidance. To test this idea, we examined motor axon projections in *TAG-1* mutant mice. We did not observe motor axon tract expansion distal to VRs (data not shown). However, in E11.5 *TAG-1^−/−^; HB9::GFP* embryos, some motoraxons deviate from their normal trajectory at the point where VRs coalesce with sensory axons and instead misproject into DRGs; in most instances, these axons reenter the spinal cord at the dorsal root entry zone (DREZ) after traversing the entire DRG ([Figure 6A](#F6){ref-type="fig"}). Motor axons do not enter DRGs in *HB9::GFP* littermates, but the DRG invasion phenotype is present in *TAG-1* heterozygous mutant animals, with a severity of about 50% relative to homozygous knockouts ([Figures 6A](#F6){ref-type="fig"} and [6B](#F6){ref-type="fig"}), indicating that this defect is sensitive to gene dosage. Analysis of whole, optically cleared E12.5 *TAG-1^−/−^; HB9::GFP* embryos revealed motor axon misprojections at all rostro-caudal levels except the most anterior cervical spinal cord (data not shown); after reentering the neural tube, motor axons join the dorsal funiculus and extend longitudinally over multiple spinal cord segments ([Figure 6C](#F6){ref-type="fig"}). DRG invasion by motor axons in *TAG-1^−/−^; HB9::GFP* embryos is not observed before E11.5 but persists through at least E13.5; even at birth, a significant number of ectopic motor axon projections remain within DRGs ([Figures S9A](#SD1){ref-type="supplementary-material"}--[S9D](#SD1){ref-type="supplementary-material"}). The delayed onset, increased duration, exclusion from the most rostral spinal cord, and gene dosage sensitivity of this *TAG-1* mutant motor axon guidance defect distinguish it from the MN emigration and VR expansion phenotypes. Together, these data indicate that TAG-1 guides motor axons past DRGs, independent from its functions in MN cell body anchoring and axon fasciculation.

Next, we sought to elucidate whether axonal misprojections into DRGs originate from MNs across different motor column identities. We injected E11.5 brachial-level DRGs with DiI and determined the motor column identity of retrogradely traced MNs in the ventral horn by IHC ([Figure 6F](#F6){ref-type="fig"}). As expected, no DiI-labeled MNs were observed in wild-type embryos ([Figure 6D](#F6){ref-type="fig"}). In *TAG-1^−/−^* embryos, we found that retrogradely traced MNs are exclusively of LMC (LMCl and LMCm) identity ([Figures 6D](#F6){ref-type="fig"}--[6F](#F6){ref-type="fig"}), accounting for about 12% of all MNs in this motor column. When we examined motor innervation of limb buds in E12.5 *TAG-1^−/−^; HB9::GFP* embryos and *HB9::GFP* littermates, we observed thinned motor axon projections in mice lacking TAG-1 ([Figure S9E](#SD1){ref-type="supplementary-material"}), consistent with a partial failure of LMC axons to reach the limb. Thus, TAG-1 is specifically required for LMC axon guidance past DRGs and into the target field.

TAG-1 Functions in Motor Neurons to Guide Motor Axons Past DRGs {#S9}
---------------------------------------------------------------

To determine whether TAG-1 acts cell autonomously to prevent motor axons from misprojecting into DRGs, we deleted *TAG-1* specifically in MNs. We found that, in E11.5 *Olig2^Cre/+^; TAG-1^cKO/cKO^; HB9::GFP* mice but not *TAG-1^cKO/cKO^; HB9::GFP* littermates, motor axons invade DRGs ([Figures 7A](#F7){ref-type="fig"} and [7C](#F7){ref-type="fig"}), indicating that MN-derived TAG-1 is required for axon guidance. We also performed *TAG-1* deletion in a subset of MNs using the *Olig2^IRES-Cre^* line and marked the targeted neurons and their axons via the *ROSA26^LSL-tdTom^* allele, which is a more sensitive label for individual motor axons than the *HB9::GFP* transgene ([Figure 7B](#F7){ref-type="fig"}). We observed GFP^+^ motor axon invasion of DRGs in *Olig2^IRES-Cre/+^; TAG-1^cKO/cKO^; ROSA26^LSL-tdTom/+^; HB9::GFP* embryos ([Figures 7B](#F7){ref-type="fig"} and [7C](#F7){ref-type="fig"}), demonstrating that stochastic deletion of *TAG-1* is sufficient to elicit the axon guidance defect. While most of the misprojecting GFP^+^ motor axons are also tdTomato^+^, a small fraction appears negative for tdTomato ([Figures 7D](#F7){ref-type="fig"} and [7E](#F7){ref-type="fig"}), supporting the idea that the *TAG-1* mutant DRG invasion phenotype is mostly cell autonomous but that misrouted TAG-1-deficient motor axons can occasionally pull wild-type axons into the DRG with them. In both conditional knockout lines, the extent of DRG invasion by motor axons is lower than in the complete knockout and more closely resembles the *TAG-1* heterozygous null ([Figure 7C](#F7){ref-type="fig"}; compare to [Figure 6B](#F6){ref-type="fig"}). Together, these results indicate that TAG-1 in MNs helps guide motor axons past DRGs, but they also suggest that sources of TAG-1 other than MNs, such as sensory neurons, might contribute to this function.

DISCUSSION {#S10}
==========

During development, MNs project axons to peripheral targets while their cell bodies remain in the CNS. We demonstrate that MN-expressed TAG-1 anchors MN somata in the spinal cord to prevent their emigration, mediates motor axon fasciculation during CNS exit, and helps guide LMC axons to their target field. We provide evidence that these multiple functions of TAG-1 during different stages of spinal MN wiring are independent from each other. These results identify TAG-1 as a multifunctional regulator of MN development that coordinates neuronal migration, axon fasciculation, and axon guidance, likely through at least partially separate molecular mechanisms.

TAG-1 Anchors Motor Neuron Cell Bodies in the Spinal Cord {#S11}
---------------------------------------------------------

To be in position for receiving appropriate presynaptic inputs, MNs must be prevented from following their axons into the periphery. Sema6A-Nrp2 and Netrin5-DCC signaling from boundary cap cells to MNs have been implicated as important contributors to this process ([@R6]; [@R17]; [@R44]; [@R63]). Moreover, radial glia endfeet have been proposed to form a barrier for migrating MNs at MEPs, as *Reelin* mutant mice exhibit disorganization of spinal cord radial glia and MN mispositioning outside the neural tube ([@R33]). With few, incompletely understood exceptions ([@R1]; [@R26]; [@R34]; [@R62]), additional mechanisms that help contain MNs within the spinal cord have remained elusive.

We find that TAG-1 is expressed on and required in migrating MNs, across motor column identities, to prevent their exit from the spinal cord *in vivo*. MN emigration in mice lacking TAG-1 is more severe than in *Sema6A, Nrp2*, and *Netrin5* mutant mice, indicating that TAG-1 does not control MN positioning solely by mediating either Sema6A-Nrp2 or Netrin5-DCC signaling. Furthermore, the *TAG-1* mutant phenotype is also stronger than what is observed in mice with disorganized radial glia end-feet, and detailed phenotype analysis of *TAG-1* knockout mice demonstrates that TAG-1 does not prevent MN emigration by regulating radial glia or boundary cap cell organization at MEPs. *In vitro* analysis shows that TAG-1 anchors MNs in the spinal cord independently from any interactions with peripheral tissues and indicates that TAG-1 on MN somata tethers MNs in the ventral horn through homophilic adhesion, consistent with TAG-1's ability to engage in homo- and heterophilic adhesive interactions ([@R12]; [@R47]). Sparse *TAG-1* deletion in about 40% of MNs shows that TAG-1 does not act in a strictly cell-autonomous manner and suggests that TAG-1-mediated adhesion between the majority of MNs can prevent spinal cord exit of individual TAG-1-deficient MNs, possibly via other CAMs or by physically trapping these MNs. Combined with previous findings, our results highlight the multiplicity of both spinal cord-intrinsic and -extrinsic mechanisms that collaborate in containing MNs within the spinal cord ([@R60]).

Previously, TAG-1 has been implicated in facilitating facial MN migration in the zebrafish hindbrain ([@R19]). This contrasts with our finding that TAG-1 restricts, rather than promotes, migration and aberrant spinal cord exit of MNs in the mouse hindbrain. How TAG-1 might act as an either pro- or anti-migratory factor in different contexts or organisms remains to be determined.

TAG-1 Mediates Axon-Axon Interactions for Motor Axon Fasciculation {#S12}
------------------------------------------------------------------

Motor axons are tightly fasciculated en route to their target fields. Various mechanisms promote motor axon bundling during different stages of growth, including surround repulsion by Semaphores, autocrine Slit-Robo signaling, and ALCAM-mediated axon-axon adhesion ([@R21]; [@R22]; [@R23]; [@R45]; [@R68]). Additional molecules are likely to contribute to motor axon fasciculation.

Nascent motor axons express TAG-1, and we find that global or MN-specific *TAG-1* deletion causes disorganization and expansion of VRs, but not of more distal motor axon tracts. Detailed *TAG-1^−/−^* phenotype analysis provides multiple lines of evidence that this defect is not a consequence of additional cells or axons in VRs. *In vitro* results directly demonstrate TAG-1-dependent motor axon fasciculation without signaling from tissues in the spinal cord periphery and indicate that TAG-1 homophilic binding mediates axon-axon adhesion. Collectively, these findings support the idea that TAG-1 on motor axons controls VR size by promoting motor axon interactions and fasciculation, consistent with TAG-1's function in mediating fasciculation in multiple other neuronal populations ([@R7]; [@R29]; [@R41]; [@R51]; [@R58]; [@R59]). It remains to be determined why TAG-1-dependent fasciculation is specifically required during early motor axon growth and VR formation, but not at later stages.

TAG-1 Guides LMC Axons Past DRGs {#S13}
--------------------------------

To reach their final destinations, motor axons avoid inappropriate targets along the way. Multiple studies indicate that motor axons need to be actively prevented from projecting into DRGs after exiting the spinal cord, as subsets of motor axons invade DRGs in *EphA3/4* double knockouts, *EfnB1^−/−^* mice, CNS-specific *FGFR1* knockouts, and *Robo1/2* double mutants ([@R16]; [@R27]; [@R36]; [@R56]). Additionally, overexpression of Sema3A in MNs causes motor axon misprojection into DRGs ([@R45]). However, the precise mechanisms that promote or prevent motor axon entry into DRGs have remained elusive.

We find that motor axons express TAG-1 as they navigate through the periphery and that, in mice lacking TAG-1, they misproject through DRGs and reenter the spinal cord at the DREZ. The developmental timing, MN subtype specificity, and TAG-1 protein level sensitivity of this phenotype indicate that it is not a secondary consequence of impaired MN anchoring or motor axon fasciculation. At brachial level, only LMC, but not MMC, axons enter DRGs in *TAG-1* mutant mice, demonstrating that TAG-1 specifically guides LMC axons past DRGs. However, presence of the motor axon projection defect along most of the rostro-caudal axis suggests that TAG-1 guides additional, likely non-MMC motor axons at other spinal cord levels. Because EphA and FGFR1 signaling prevent MMC, not LMC, axons from entering DRGs ([@R16]; [@R56]), our results indicate that TAG-1 is not a mediator of these pathways in motor axon guidance. TAG-1 can facilitate Semaphorin signaling, and previous work implicates class III Semaphorins in repelling motor axons from DRGs ([@R45]), but motor axons do not invade DRGs in mice lacking the Semaphorin receptors Nrp1, Nrp2, PlexinA3, or PlexinA4 (this study; unpublished data). This argues against a requirement for Semaphorin repulsion in guiding motor axons past DRGs. TAG-1 also promotes axonal responses to other, as-yet-unidentified, repellants ([@R32]; [@R41], [@R42], [@R43]), leaving open the possibility that TAG-1-dependent repulsion from these cues prevents motor axons from entering DRGs. Analysis of *Robo1/2* mutants revealed sporadic motor axon misprojections into DRGs with much lower phenotype severity compared to *TAG-1* knockouts (unpublished data), indicating that TAG-1 does not guide motor axons by mediating Slit repulsion. The precise molecular mechanism for TAG-1-dependent motor axon guidance remains elusive, but MN-specific deletion of *TAG-1* demonstrates that TAG-1 expression on motor axons is important for this function. Our results underscore the necessity of multiple signals that prevent motor axon entry into DRGs and identify a LMC-specific mechanism. Differences in the timing of axon extension or the existence of redundant mechanisms in MMCs (such as EphA-mediated repulsion) might explain why LMC axons require TAG-1 to avoid DRGs while MMC axons do not, despite both populations expressing TAG-1. Because MN-specific *TAG-1* deletion does not fully reproduce the *TAG-1^−/−^* axon guidance phenotype, additional sources of TAG-1 likely contribute to its guidance function. DRG sensory neurons express high levels of TAG-1 and are therefore a strong candidate, but further investigation is needed to determine whether, and how, MN- and DRG-derived TAG-1 collaborate to prevent motor axons from entering DRGs.

TAG-1 Multifunctionality Coordinates Sequential Steps in Neuronal Wiring {#S14}
------------------------------------------------------------------------

Our results show that TAG-1 mediates MN cell body anchoring, motor axon fasciculation, and motor axon guidance, and we provide strong evidence that these three functions of TAG-1 are not interdependent. Of note, both MN soma anchoring and motor axon bundling appear to rely on homophilic adhesion via TAG-1, yet the severity of axon defasciculation after loss of TAG-1 exceeds that of cell body overmigration. The lack of correlation between these two phenotypes underscores their independence from one another, but it also raises the question which factors render individual MNs vulnerable to either of the defects. Partially redundant adhesive interactions between MN cell bodies, mediated by CAMs other than TAG-1, might well explain why only a subset of MNs is susceptible to spinal cord exit in *TAG-1^−/−^* mice. Furthermore, our time course analysis of TAG-1 expression in MNs shows that TAG-1 is first present on cell bodies and gradually redistributes to nascent axons. As axons continue to extend, TAG-1 localizes exclusively to their distal segments, consistent with the previous *in vitro* observation of selective TAG-1 delivery to growth cones ([@R64]). This dynamic, sequential targeting to neuronal somata and axons might allow TAG-1 to independently mediate its multiple functions during sequential stages of MN wiring by engaging distinct molecular pathways or by acting in different cellular compartments.

Motor Neuron Wiring Defects after Loss of TAG-1 Are Partially Corrected during Later Development {#S15}
------------------------------------------------------------------------------------------------

Despite their defects in MN migration and wiring, mice lacking TAG-1 are postnatally viable ([@R14]; [@R46]), although they have been reported to exhibit gait abnormalities and impaired performance on a rotarod ([@R52], [@R53]). This suggests that motor circuitry in adult *TAG-1* mice is largely normal, with limited functional consequences. Our results show that the early VR expansion phenotype in *TAG-1* mutants disappears by E13.5, since VR diameter in wild-type mice gradually increases to match the knockout. It is possible that, during this E9.5-E13.5 time period, newly emerging axons in *TAG-1* mice project through gaps between less fasciculated, earlier projecting axons, and ventral root diameter therefore remains essentially constant. Compensatory upregulation of other CAMs that can drive motor axon fasciculation is an alternative explanation for recovery of the mutant phenotype. As for the *TAG-1^−/−^* MN emigration and motor axon guidance defects, ectopic MNs are no longer detected at birth, and the DRG invasion phenotype is strongly diminished, yet not fully abolished by P0. This suggests that mispositioned MNs undergo apoptosis and misprojecting motor axons are largely pruned over time, likely due to lack of trophic support. Collectively, these results highlight the plasticity of developing motor circuits and their ability to correct defects in early MN wiring. This plasticity is at least partly afforded by the overproduction of MNs during development and the subsequent removal of neurons that fail to successfully integrate into functional circuits.

STAR★METHODS {#S16}
============

LEAD CONTACT AND MATERIALS AVAILABILITY {#S17}
---------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Alexander Jaworski (<alexander_jaworski@brown.edu>). All unique reagents, including mouse lines, generated in this study are available from the lead contact.

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S18}
--------------------------------------

### Animals {#S19}

All experimental procedures had institutional approval through Brown University's Institutional Animal Care and Use Committee and followed the guidelines provided by the National Institutes of Health. Mouse lines were maintained in a CD-1 (*TAG-1^−/−^; HB9::GFP*) or mixed CD-1 / C56bl6 background (all other lines). For timed pregnancies, the day of vaginal plug was defined as E0.5, and littermate embryos of either sex were used for all experiments. Spinal cord sizes did not differ significantly between littermates of different genotypes (data not shown), indicating comparable overall development.

Mouse strains used were: TAG-1^cKO^, *TAG-1^−/−^* (MGI: 2677610, official nomenclature Cntn2^tm1Furl^) ([@R46]), *E2A::Cre* (MGI: 2137691, official nomenclature Tg(EIIa-cre)C5379Lmgd) ([@R30]), *Olig2^Cre/+^*(MGI: 3774124, official nomenclature Olig2^tm1(cre)Tmj^) ([@R10]), *Olig2^IRES-Cre/+^* (MGI: 4461156, official nomenclature Olig2^tm1.1(cre)Wdr^) ([@R75]), *HB9::GFP* (MGI: 3056906, official nomenclature Tg(Hlxb9-GFP)1Tmj) ([@R69]), *ROSA26^LSL-tdTom/+^* (MGI: 3809523, official nomenclature Gt(ROSA)26Sor^tm9(CAG-tdTomato)Hze^)([@R37]), *Sema6A*(MGI: 2156202, official nomenclature Sema6a^Gt(KST069)Byg^) ([@R35]), *Nrp2^cKO/cKO^* (MGI: 3712029, official nomenclature Nrp2^tm1.1Mom^) ([@R65]), *Nrp1^cKO/cKO^*(MGI: 3512101, official nomenclature Nrp1^tm2Ddg^) ([@R18]), *PlexinA3^−/−^* (MGI: 2386961, official nomenclature Plxna3^tm1Matl^) ([@R8]), *PlexinA4^−/−^* (MGI: 3579185, official nomenclature Plxna4^tm1Matl^) ([@R74]), and *FLPeR* (MGI: 2429412, official nomenclature Gt(ROSA)26Sor^tm1(FLP1)Dym^) ([@R11]). These mouse lines were genotyped as previously reported.

### Cell lines {#S20}

CV-1 in Origin with SV40 genes (COS-7) cell lines (ATCC, Catalog \#CRL-1651) were grown as previously described ([@R23]) at 37°C with 5% CO2.

### *In vitro* primary cell cultures {#S21}

Primary motor neurons from E11.5 embryos of both sexes were dissected in L-15 media (GIBCO) with 5% horse serum. Neurons were placed in 8-chamber glass slides, which had been pre-coated with 1 mg/ml poly-D-Lysine (PDL; Sigma, \#P6407) in water and 50 ng/ml laminin (Millipore, \#CC095) in PBS (control conditions). For TAG-1 substrate conditions, 50 mg/ml recombinant TAG-1 protein (TAG-1-His~10~; R&D Systems, \#1714-CN) was added to 50 ng/ml laminin with PBS and incubated overnight at 4°C prior to explant dissection. Neurons were cultured for 40--44 h in MN growth medium (10 ng/ml BDNF (Cell Science, \#CRB600B), 50 ng/mL GDNF (Sigma, \#SRP3200), 2% B-27, penicillin/streptomycin/glutamine (both Invitrogen), 0.5% glucose, and 0.5% methylcellulose in Neurobasal medium) at 37°C with 5% CO2.

METHOD DETAILS {#S22}
--------------

### Generation of *TAG-1^cKO^* mouse {#S23}

The *TAG-1^cKO^* allele was generated using a targeting construct that was assembled via a combination of gene synthesis (Blue Heron Biotechnology, Inc) and Red/ET recombineering (GeneBridges). Part of a BAC clone containing the *TAG-1* locus (CHORI, RP23-69J15) was retrieved and modified by inserting LoxP sites into non-conserved intronic regions 553bp upstream and 530bp downstream of *TAG-1* exon 2. The 3′ LoxP site was preceded by a Frt-flanked neomycin (Neo) cassette ([Figure S3](#SD1){ref-type="supplementary-material"}). The targeting vector was introduced into 129/B6 hybrid embryonic stem (ES) cells and G418-resistant colonies were screened via Southern blot using probes located outside of the vector's homology arms. The 5′- and 3′-probes were generated by PCR amplification from isolated BAC DNA (primer sequences: 5′ probe, TTAAAGGTTGACCGTAGATCTCTCTGT and GGAGGTTCAGGGGTTCTGGTT; 3′-probe, CAACATCACCTGGCTGACACA and TTTATAATGGGTCAGGCCTATCTGG). Probes were ^32^P-radiolabeled using the Prime-It II Random Primer Labeling Kit (Agilent). Correctly targeted ES cell clones were injected into B6 blastocysts at the Brown University Transgenic Services Laboratory to obtain chimeric *TAG-1^cKO-Neo/+^* mice. The Neo cassette was then deleted by crossing chimeras to *FLPeR* mice, which express FLPe recombinase from the ROSA26 locus ([@R11]), to generate *TAG-1^cKO/+^* mice.

The *TAG-1^Δ^* allele was generated by crossing *TAG-1^cKO/cKO^* mice with *E2A::Cre* mice, which express Cre recombinase in the germline ([@R30]). Deletion of TAG-1 in *TAG-1* and *TAG-1^Δ/Δ^* mice was confirmed by various methods ([Figures S1](#SD1){ref-type="supplementary-material"}, [S3](#SD1){ref-type="supplementary-material"}, and [S4](#SD1){ref-type="supplementary-material"}). Normal expression of the CAM Neurofascin, which is encoded by a genomic locus adjacent to *TAG-1* ([@R20]), in these mouse lines was confirmed by IHC on E11.5 brachial spinal cord sections (data not shown). For genotyping, *TAG-1* alleles were detected by PCR (primer sequences: Fwd1 - CATGTGGTGGGAGTGTGGCTG, Rev1 - ACATCTCTCTTCCTACTTTTCTTCCCA TAG, and Rev2 - AACTCTCCAGATGTTGGATCCCTT) from genomic DNA, yielding band sizes of 212, 246, and 173 base pairs (bps) for the *TAG-1^+^, TAG-1^cKO^*, and *TAG-1^Δ^* alleles, respectively.

### Immunohistochemistry {#S24}

All spinal cord sections were collected from brachial level unless specified otherwise. Unless indicated otherwise, all incubations were conducted at room temperature (RT). Immunohistochemistry (IHC) on cryosections were performed as previously reported ([@R24]).

Embryos for vibratome sectioning were fixed overnight at 4°C in 4% paraformaldehyde (PFA) in PBS and washed three times for 10 min in PBS. Embryos were then embedded in 2% agarose in PBS and sectioned in PBS at 100 μm, and P0 animals were embedded in 3.5% agarose in PBS and sectioned at 150 μm. Free-floating vibratome sections were incubated in blocking buffer (2.5% bovine serum albumin (BSA), 0.1% Triton X-100 in PBS for embryonic sections and 4% BSA, 0.5% Triton X-100 in PBS for P0 sections) for 3---4 h). Primary antibodies diluted in blocking buffer were added to sections and incubated at 4°C overnight. After three 20-min washes with blocking buffer, sections were incubated with secondary antibodies diluted in blocking buffer overnight at 4°C. Three washes with blocking buffer for 20 min and one rinse with PBS were completed prior to mounting sections under Fluoromount-G for imaging.

Whole embryo IHC and clearing was performed via iDISCO. Embryos were fixed in 4% PFA in PBS overnight at 4°C and washed three times for 5 min with PBS. Embryos were then processed, as previously described, using the iDISCO IHC and methanol protocol ([@R49]).

Explants and dissociated MN cultures were fixed for 2 h with 4% PFA in PBS and washed three times for 5 min in PBS. The tissue was then stained using the IHC protocol for cryosections with solutions added directly to the 8-well glass chamber slides.

Mouse antibodies raised against NF (DHSB, \#2H3, 1:500 (cryosections) or 1:200 (iDISCO)), TAG-1 (DSHB, \#4D7, 1:200), and Islet1/2 (DHSB, \#39.4D5, 1:200) were used, as well as goat antibodies raised against TAG-1 (R&D Systems, \#AF4439, 1:200) and Sox10 (Santa Cruz, \#sc-17342,1:200). All TAG-1 immunolabeling was performed using the polyclonal R&D Systems antibody unless specifically stated otherwise. Additionally, rabbit antibodies raised against TUJ1 (BioLegend, \#802001, 1:500 and Covance \#MrB-435P, 1:1000), HB9 (described previously; [@R61]; 1:10000), Neurofascin (described previously; [@R55]; 1:2000), Lhx3 (Abcam, \#ab14555, 1:400), FoxP1 (Abcam, \#ab16645, 1:500), Olig2 (Millipore, \#AB9610, 1:500) and RFP (Rockland, \#600-401-379, 1:500) and a chick antibody against GFP (Abcam, \#ab13970, 1:200) were used. Secondary antibodies were: Alexa488-conjugated donkey anti-goat, Alexa488-conjugated donkey anti-rabbit, Alexa488-conjugated donkey anti-mouse, Alexa488-conjugated goat anti-chicken, Alexa594-conjugated donkey anti-goat, Alexa594-conjugated donkey anti-rabbit, Alexa594-conjugated donkey anti-mouse, Alexa647-conjugated donkey anti-goat, Alexa647-conjugated donkey anti-rabbit, Alexa647-conjugated donkey anti-mouse, Alexa647-conjugated rabbit anti-goat, Alexa647-conjugated goat anti-chicken, Alexa555-conjugated goat anti-mouse, and Alexa488-conjugated goat anti-mouse IgM (all Invitrogen, 1:200). Alexa488 donkey anti-chicken (Jackson ImmunoResearch, 1:200) was also used. Hoechst 33342 (Invitrogen; 1:1000) was added with secondary antibodies.

### Imaging {#S25}

Cryosections were imaged on a Nikon Eclipse Ti inverted microscope with Andor CCD camera or an Olympus FV3000 confocal laser scanning microscope. Vibratome sections were imaged using either a Zeiss LSM 810 confocal microscope, Zeiss LSM 510 meta confocal microscope, or Olympus FV3000 confocal microscope. Embryos cleared with iDISCO were either imaged on a Zeiss LSM 510 meta confocal laser scanning microscope with a 10x/0.45 Plan Apochromat objective or a LaVision Biotec light sheet microscope (Ultramicroscope II) equipped with a 2x/0.5 objective lens (MVPLAPO 2x) with 6mm working distance dipping cap, a sCMOS camera (Andor Neo), and Imspector Microscope controller software.

### Assignment of motor column identity {#S26}

To differentiate between motor columns at brachial level, spinal cord sections were immunolabeled for the transcription factors Islet1/2 and FoxP1. MMC MNs are immunoreactive only for Islet1/2; the LMC contains LMCl neurons, which are labeled by the FoxP1 antibody and exhibit weak Islet1/2 immunoreactivity, and LMCm neurons, which are strongly co-labeled by both the FoxP1 and Islet1/2 antibodies ([@R13]; [@R57]). For cervical and thoracic levels, spinal cord sections were immunolabeled for the transcription factors Islet1/2 and Lhx3. MMC MNs are immunoreactive for Islet1/2 and Lhx3, while all non-MMC MNs (hypaxial motor column, preganglionic motor column, phrenic motor column, and spinal accessory column) only exhibit Islet1/2 immunoreactivity ([@R57]).

### DiI tracing {#S27}

Dil (Invitrogen, \#V22888) was injected into either the DRG ([Figure 6F](#F6){ref-type="fig"}) or the dorsal spinal cord ([Figure S8E](#SD1){ref-type="supplementary-material"}) of intact, fixed embryos (see [IHC section for fixation method](#S22){ref-type="sec"}) using a micropipette and incubated in PBS for 24 h in the dark. Embryos were then vibratome-sectioned (see [IHC methods](#S22){ref-type="sec"}). For DiI tracing from VRs ([Figure S8E](#SD1){ref-type="supplementary-material"}), fixed embryos were first embedded in 2% agarose and vibra-tome-sectioned at 150 μm. DiI was then injected into VRs using a micropipette, and free-floating sections were incubated in PBS for 24 h in the dark. Sections were then fixed for 10 min with 4% PFA in PBS and washed three times for 5 min with PBS before proceeding with the vibratome section IHC protocol (see above). This protocol was modified by replacing Triton X-100 with 0.1% Tween-20 in all blocking buffers, and no detergent was used in any wash buffers.

### Fluorescent *in situ* hybridization {#S28}

Embryos were fixed with 4% PFA in PBS and cryosectioned at 20 μm under RNase-free conditions. Slides were then processed according to the ACD RNAscope fresh frozen tissue pretreatment and fluorescent multiplex assay manual. The Mm-Egr2 probe (ACD Bio-techne, \#407871), which has been described previously ([@R2]; [@R39]), was used. IHC on cryosections (see above) was performed following completion of the RNAscope protocol.

### Cell culture {#S29}

COS-7 cells were grown as previously described ([@R23]). The mouse *TAG-1* coding sequence under control of a combined CMV/b-actin enhancer/promoter (or empty vector as negative control) were introduced into cells using Viofectin (Viogene, \#VFT1001), following the manufacturer-recommended protocol.

### Western blot analysis {#S30}

For western blot analysis of embryonic tissue, the spinal column area (spinal cord, DRGs, and surrounding tissue) was dissected, lysed, and homogenized. COS cells were lysed and homogenized 24 h after transfection. Lysis/homogenization was performed on ice, and all subsequent incubation steps were conducted at RT unless otherwise specified. Protein concentration was determined by BCA protein assay (Pierce, \#23335), and equal amounts of protein, falling within the linear range of western blot detection, were separated using 4%--12% Bis-Tris polyacrylamide gels (Bio-Rad, \#3450124) and blotted onto Immobilon-P PVDF membranes (Millipore, \#IVPH00010). Membranes were rinsed three times in TBST (20mM Tris base, 150mM NaCl, 0.1% Tween 20, pH 7.5) and cut between the 50-kD and 75-kD protein ladder bands (Kaleidoscope protein ladder, Bio-Rad, \#1610375) to allow for the separate detection of TAG-1 (≈135 kD) and β-actin (≈42 kD). Membranes were blocked in 5% non-fat dry milk in TBST before being incubated with primary antibody in blocking buffer overnight at 4°C. Membranes were then incubated with HRP-conjugated secondary antibodies for 2 h, quickly rinsed three times with TBST, and then washed three times for 5 min with TBST. Blots were developed using SuperSignal™ West Dura Extended Duration Substrate (Pierce, \#32106) for 1 min and imaged on an Azure C series digital imager. Primary antibodies used were goat anti-TAG-1 (R&D system, \#AF4439, 1:25) and rabbit anti-β-actin (Novus, \#NB600-503, 1:200). Secondary antibodies used were HRP-conjugated donkey anti-goat (Jackson ImmunoResearch, \#705-035-003, 1:2500) and HRP-conjugated goat anti-rabbit (Jackson ImmunoResearch, \#111-035-144,1:1500). Protein band intensities were quantified using ImageJ. TAG-1 band intensities were normalized to β-actin loading controls.

### Ventral spinal cord explant and neuron culture {#S31}

E11.5 embryos were harvested in L-15 media (GIBCO) with 5% horse serum. The Royal Blue NightSea system (Electron Microscopy Sciences, \#SFA-LFS-RB) was used to identify HB9::GFP^+^ embryos for dissection. To generate ventral spinal cord explants, open-book preparations of E11.5 mouse brachial and cervical spinal cords were used. Under NightSea fluorescent illumination, the ventral third of the spinal cord, containing GFP^+^ MNs but excluding the floor plate, was collected and cut into approximately square explants. Ventral spinal cord explants were plated in 8-chamber glass slides, which had been pre-coated with 1 mg/ml poly-D-Lysine (PDL; Sigma, \#P6407) in water and 50 ng/ml laminin (Millipore, \#CC095) in PBS (control conditions). For TAG-1 substrate conditions, 50 μg/ml recombinant TAG-1 protein (TAG-1-His~10~; R&D Systems, \#1714-CN) was added to 50 ng/ml laminin with PBS and incubated overnight at 4°C prior to explant dissection. Explants were cultured for 40-44 h in MN growth medium (10 ng/ml BDNF (Cell Science, \#CRB600B), 50 ng/mL GDNF (Sigma, \#SRP3200), 2% B-27, penicillin/streptomycin/glutamine (both Invitrogen), 0.5% glucose, and 0.5% methylcellulose in Neurobasal medium) at 37°C before processing for IHC (see above).

Dissociated MN cultures were generated by dissecting out the ventral spinal cord from an open book preparation (see above). Dissociation into single-cell suspension was conducted as described before ([@R31]). Cells were plated at low density on PDL- and laminin-coated 8-well chamber slides and cultured for 24 h in MN growth medium before processing for IHC.

QUANTIFICATION AND STATISTICAL ANALYSIS {#S32}
---------------------------------------

### TAG-1 expression in motor neuron subtypes {#S33}

To determine TAG-1 expression across motor columns, the number of TAG-1-immunolabeled MNs belonging to different brachial motor columns (see above; MMC (Islet1/2^+^), LMCl (FoxP1^+^), LMCm (Islet1/2^+^/FoxP1^+^)) was determined and expressed as a fraction of the total number of MNs within these columns. These quantifications were carried out on spinal cord cryosections.

### Ectopic motor neurons {#S34}

MNs were considered ectopic if the nucleus had broken the edge of the spinal cord at the MEP or left the spinal cord completely. To quantify the number of ectopic MNs per VR, 100 μm vibratome sections from embryos carrying the *HB9::GFP* transgene were stained for Islet1/2. The total number of Islet1/2^+^/GFP^+^ MNs within the VR and more distal motor nerve segment was counted. Time course analysis of ectopic MNs was performed using cryosections stained for HB9. The total number of HB9^+^ MNs outside the spinal cord per hemisection with a visible VR were counted. To quantify the number of ectopic MNs per motor column, cryosections were stained for motor column markers (see above), and ectopic neurons were counted per VR-containing hemisection.

### Motor column mixing {#S35}

To quantify motor column spatial organization, ImageJ software was used to create ROIs outlining the MMC and LMC within each hemisection, as defined by FoxP1 and Islet1/2 staining (see above). The perimeters of the LMC (ROI~LMC~) and the MMC (ROI~MMC~) encompassed each column's total area and was defined by vertices placed on the somas of the most peripheral cells within each column. A third ROI, which encompassed the area of overlap between the two columns, was then generated (ROI~overlap~). All defined ROIs were convex polygons (interior angles \< 180°). The areas of the three ROIs (A~LMC~, A~MMC~, and A~overlap~) were then measured using ImageJ. The amount of overlap between the LMC and MMC was expressed as A~overlap~/(A~LMC~ + A~MMC~ − A~overlap~).

### Ventral root diameter {#S36}

VR diameter quantification in 100 μm vibratome sections from embryos carrying the *HB9::GFP* transgene was conducted using ImageJ. Maximum-intensity projections were generated from confocal z stacks containing entire VRs. The diameter of the root was measured perpendicular to the VR at a distance of 30 μm from the MEP. All GFP^+^ axons were included in the measurement ([Figures 4A](#F4){ref-type="fig"} and [5A](#F5){ref-type="fig"}), and VR diameter was expressed as a percentage of the average for control littermates. For the time course analysis of VR diameter, maximum-intensity projections of z stacks from NF-stained, iDISCO-cleared embryos were generated and used to measure each VR maximum diameter in the transverse plane using ImageJ ([Figure S7A](#SD1){ref-type="supplementary-material"}). Measurements were taken at different distances from the spinal cord depending on age: E9.5 -- 20 μm, E10.5 -- 30 μm, E11.5 -- 30 μm, E12.5 -- 35 μm, and E13.5 -- 40 μm. Quantification of VR diameter from longitudinal cryosections was performed as previously reported ([Figure S7B](#SD1){ref-type="supplementary-material"}) ([@R50]).

### Motor axon DRG invasion {#S37}

To quantify motor axon invasion of DRGs, maximum-intensity projections of z stacks collected from 100 μm vibratome sections of embryos and 150 μm vibratome sections from P0 animals carrying the *HB9::GFP* transgene were generated. Using the ImageJ plugin NeuronJ, the total summed length of all GFP^+^ motor axons was quantified per DRG. Measurements were made from the point where motor axons left the main VR and covered the entire arbor within the DRG. In *Olig2^IRES-Cre/+^; TAG-1^cKO/cKO^; ROSA26^LSL-tdTom/+^; HB9::GFP* embryos, DRG invasion was quantified based on GFP^+^, tdTom^+^, and GFP^+^/tdTom^+^ motor axons.

### DiI retrograde tracing {#S38}

Following DiI injection into DRGs and IHC staining of vibratome sections, DiI^+^ MNs were counted and assigned motor column identity (see above). Individual optical sections from z stacks were used to unambiguously identify cells positive for both DiI and motor column markers. The number of DiI^+^ MNs in different motor columns was expressed as a fraction of the total number of MNs within these columns.

### *In vitro* migration and axon fasciculation {#S39}

Quantification of MN migration *in vitro* was completed in ImageJ using cell counter and measurement tools. The total number of GFP^+^/Hoechst^+^ MNs that had fully emigrated from their explant (defined by solid Hoechst^+^ area) was counted. The explant diameter was measured (in μm) and used to normalize the number of migrating neurons to the size of the explant. Quantification of *in vitro* motor axon fasciculation was performed by measuring the diameter of all GFP^+^ fascicles at a distance of 100 μm away from the edge of the explant. These measurements were made using the automated measurement tool in the NIS Elements software, and correct diameter measurements were confirmed by eye. We defined five bins (0-2.5 μm, 2.5-5 μm, 5-7.5 μm, 7.5-10 μm, and 10+ μm) and calculated the total number of fascicles that fell into each bin. These counts were then normalized to the total number of GFP^+^ fascicles for the entire experiment, so that the number of bundles within each bin was expressed as a percentage of total fascicle number.

### Motor neurons with Cre activity {#S40}

To determine the proportion of MNs with Cre activity, tdTom^+^ (and therefore Cre-expressing) cells in E9.5 Olig2-labeled or E11.5 Islet1/2-labeled cryosections from *Olig2^IRES-Cre/+^; ROSA26^LSL-tdTom/+^* and *Olig2^Cre/+^; ROSA26^LSL-tdTom/+^* embryos were counted using ImageJ cell counter. The numbers of Olig2^+^/tdTom^+^ or Islet1/2^+^/tdTom^+^ neurons were expressed as fractions of the overall total number of Olig2^+^ or Islet1/2^+^ cells, respectively.

### TAG-1 immunofluorescence analysis {#S41}

Quantification of TAG-1 fluorescence intensity was performed using Nikon NIS Elements software. All cryosections were stained in parallel and imaged using identical, sub-saturating exposure times for the TAG-1, TUJ1, and Hoechst channels. For each hemisection, 3-5 ROIs were drawn into each anatomical structure based on TUJ1 staining (TAG-1 channel was hidden to prevent selection bias). The amount of summed fluorescence signal for each of the TUJ1 and TAG-1 channels in each ROI was measured in arbitrary units (a.u.). Background fluorescence was measured by placing ROIs within the (TAG-1-and TUJ1-negative) progenitor zone of each section analyzed. Fluorescence measurements for TAG-1 and TUJ1 from each ROI within a given anatomical structure were averaged across the hemisection, resulting in one fluorescence measurement per protein per anatomical structure, from which background fluorescence was then subtracted. TAG-1 fluorescence intensity was then normalized to TUJ1 fluorescence intensity.

### Motor neuron, Schwann cell, and boundary cap cell count {#S42}

HB9^+^ MNs within the spinal cord were counted per cryosection and normalized to total spinal cord cross-section area. Schwann cell quantification was conducted by staining cryosections for Sox10. All Sox10^+^ cells within VRs were counted, and TUJ1 staining was used to determine the VR area, which was traced and measured using ImageJ. The total number of Sox10^+^ Schwann cells was normalized to VR area. Quantification of boundary cap cells at MEPs was performed on cryosections after *Krox20 in situ* hybridization and Sox10 IHC. VR-associated, dual Sox10^+^/Krox20^+^ cells were counted per VR-containing hemisection.

### Statistical analysis {#S43}

A minimum of 3 embryos (biological replicates, n) were examined for all descriptive statistics (exact n for each analysis is indicated in figure legends or in the Results section). For all tissue section analyses, quantification was performed on hemisections, with the number of hemisections per n ranging from 6 to 27. For *in vitro* analyses, a total of 4-22 explants per embryos were analyzed. Values from multiple hemisections or explants per embryo were averaged, generating a single mean value per n. The averages and SEMs across biological replicates within each experimental group were calculated and displayed graphically or stated in the Results section. Analysis of *in vitro* experiments using control versus TAG-1 substrate were analyzed using paired two-tailed t tests when comparing within the same genotype. All remaining pairwise comparisons between groups were performed using unpaired, two-tailed t tests with *p* values indicated in figures or the Results section. Multiple comparisons were performed by one-way ANOVA, followed by Holm's post hoc test (α = 0.05), with *p* values shown in figures. All data were blinded prior to analysis to prevent scoring bias.

DATA AND CODE AVAILABILITY {#S44}
--------------------------

This study did not generate any unique datasets or code.
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![TAG-1 Is Expressed on Motor Neuron Cell Bodies and Axons during Early Stages of Differentiation\
(A) Schematic depicting transverse sections of mouse embryonic spinal cord (green) and limb bud (red), as shown in (B--D) and (F). Right panel shows organization of motor columns in brachial spinal cord ventral horn.\
(B and C) Time course of TAG-1 expression in brachial, ventral spinal cord (dashed outlines), visualized using an antibody against TAG-1 and other markers. (B) At E9.0, TAG-1 is expressed on all HB9^+^ MNs (arrowhead) and their growth cones (arrow). Hoechst stain labels cell nuclei. (C) At E9.5 and 10.5, Islet1/2^+^ MNs express TAG-1 on their cell bodies (arrowheads). Motor axons in VRs (arrows) express TAG-1 between E9.5 and E11.5. TUJ1 antibody against class III β-tubulin labels all axons, and Islet1/2 immunostaining labels MNs in the spinal cord and sensory neurons in the DRG (dotted line).\
(D) E10.5 brachial spinal cord was stained with antibodies against TAG-1, FoxP1, and Islet1/2 to detect TAG-1 in MMC, LMCl, and LMCm neurons (see [STAR Methods](#S16){ref-type="sec"}). TAG-1 is expressed by neurons belonging to all motor columns (arrowheads; in single-channel images, green indicates positive and red indicates negative for that marker).\
(E) Quantification of TAG-1^+^ neurons in MMC, LMCl, and LMCm shows TAG-1 expression across motor columns (n = 3 embryos).\
(F) Limb bud transverse sections from E12.5 *HB9::GFP* embryos were stained with antibodies against TAG-1 and the panaxonal marker neurofilament (NF). TAG-1 is present on NF^+^/GFP^+^ motor axons (arrows), as well as sensory axons (NF^+^ only).\
Scale bars: 25 μm in (B); 50 μm in (C), (D), and (F). Error bars indicate SEM.](nihms-1553326-f0001){#F1}

![Motor Neurons Leave the Spinal Cord in *TAG-1^−/−^* Mice\
(A) Brachial spinal cord transverse sections of E11.5 wild-type and *TAG-1^−/−^* embryos were labeled with antibodies against HB9 and TUJ1, and Hoechst stain. MN cell bodies are found within axon tracts outside of the spinal cord in *TAG-1^−/−^* embryos (arrowheads), but not wild-type littermates.\
(B) Quantification of ectopic MNs per VR shows significantly increased MN emigration in E11.5 *TAG-1^−/−^* embryos compared to wild-type and *TAG-1^+/−^* littermates (n = 3--5 embryos per genotype).\
(C) Quantification of ectopic MNs from spinal cord hemisections in wild-type and *TAG-1^−/−^* embryos over time shows significantly increased MN emigration in *TAG-1^−/−^* mice between E10.5 and E13.5 (n = 4--8 embryos per age per genotype).\
(D) E11.5 *TAG-1^−/−^* spinal cord sections were stained for FoxP1, Islet1/2, and nuclei. MMC, LMCl, and LMCm MNs are present outside of the spinal cord (arrowheads; in single-channel images, green indicates positive and red indicates negative for that marker). The dashed line indicates edge of spinal cord, and the dotted line indicates DRG.\
(E and F) Quantification of MNs outside (E) and inside the spinal cord (F) of wild-type and *TAG-1^−/−^* embryos shows significant MN emigration in *TAG-1^−/−^* mice across motor columns but no significant change of MN numbers in the spinal cord (n = 4--5 embryos per genotype).\
Scale bars: 50 μm. Error bars indicate SEM.](nihms-1553326-f0002){#F2}

![TAG-1 in Motor Neurons Prevents Emigration from the Ventral Horn\
(A) Vibratome spinal cord sections from E11.5 *TAG-1^cKO/cKO^; HB9::GFP* and *Olig2^Cre/+^; TAG-1^cKO/cKO^; HB9::GFP* embryos were stained for Islet1/2 and TUJ1. MNs are found within VRs of *Olig2^Cre/+^; TAG-1^cKO/cKO^; HB9::GFP* embryos (arrowheads), but not *TAG-1^cKO/cKO^; HB9::GFP* littermates.\
(B) Quantification of ectopic MNs per VR shows significantly increased MN emigration in *Olig2^Cre/+^; TAG-1^cKO/cKO^; HB9::GFP* embryos (n = 4--6 embryos per genotype).\
(C) Ventral spinal cord explants from E11.5 *HB9::GFP* and *TAG-1^−/−^; HB9::GFP* embryos were cultured and stained for GFP and Hoechst. GFP^+^ MNs migrate out of *TAG-1^−/−^; HB9::GFP* explants (arrowheads). The red dashed lines indicate the edge of explants.\
(D) Quantification of MNs outside of explants shows significantly more MNs migrating out of *TAG-1^−/−^; HB9::GFP* explants compared to *HB9::GFP* controls (n = 6--8 embryos per genotype).\
(E) Ventral spinal cord explants from E11.5 *HB9::GFP* and *TAG-1^−/−^; HB9::GFP* embryos were cultured on either control substrate or recombinant TAG-1 (TAG-1-His~10~)-coated substrate and stained for GFP and Hoechst. MNs emigrate from *TAG-1^−/−^; HB9::GFP* explants on both substrates, as well as from *HB9::GFP* explants on TAG-1 (arrowheads). The red dashed lines indicate the edge of explants.\
(F) Quantification of MN migration outside of explants shows significantly more MNs migrating out of *HB9::GFP* explants on TAG-1 substrate compared to control substrate or *TAG-1^−/−^; HB9::GFP* explants on TAG-1 (n = 7 embryos per genotype).\
Scale bars: 50 μm in (A); 100 μm in (C) and (E). Error bars indicate SEM.](nihms-1553326-f0003){#F3}

![Ventral Roots Are Expanded in *TAG-1^−/−^* Mice\
(A) Brachial spinal cord transverse sections from E11.5 *HB9::GFP* and *TAG-1^−/−^; HB9::GFP* embryos. GFP^+^ VR diameter (lines) is increased in *TAG-1^−/−^; HB9::GFP* mice.\
(B) Quantification of VR diameter shows significant expansion in E11.5 *TAG-1^−/−^; HB9::GFP* embryos compared to *HB9::GFP* and *TAG-1^+/−^; HB9::GFP* littermates (n = 3--6 embryos per genotype).\
(C) Time course analysis of VR diameter in wild-type and *TAG-1^−/−^* embryos using iDISCO visualization of NF (see [STAR Methods](#S16){ref-type="sec"}) shows significant root expansion between E9.5 and E12.5 (n = 4--5 embryos per genotype per age).\
(D) Correlation analysis of ectopic MN number per VR and root diameter in E11.5 *TAG-1^−/−^; HB9::GFP* embryos (analyzed in [Figures 2B](#F2){ref-type="fig"} and [4B](#F4){ref-type="fig"}) reveals no significant relationship between these parameters (n = 74 VRs from 5 embryos).\
Scale bar: 50 μm. Error bars indicate SEM.](nihms-1553326-f0004){#F4}

![TAG-1 in Motor Neurons Promotes Axonal Fasciculation\
(A) Transverse sections of E11.5 *TAG-1^cKO/cKO^; HB9::GFP* and *Olig2^Cre/+^; TAG-1^cKO/cKO^; HB9::GFP* brachial spinal cord. GFP^+^ VR diameter (lines) is increased in *Olig2^Cre/+^; TAG-1^cKO/cKO^; HB9::GFP* mice.\
(B) Quantification of VR diameter shows significant expansion in *Olig2^Cre/+^; TAG-1^cKO/cKO^; HB9::GFP* embryos compared to *TAG-1^cKO/cKO^; HB9::GFP* (n = 4--6 embryos per genotype).\
(C) Ventral spinal cord explants from E11.5 *HB9::GFP* and *TAG-1^−/−^; HB9::GFP* embryos were cultured and labeled with GFP antibody and Hoechst stain. The dashed box indicates area of magnified inset. GFP^+^ motor axons from *HB9::GFP* explants form thicker fascicles (red arrowhead) than axons from *TAG-1^−/−^; HB9::GFP* explants. The white arrowheads indicate precociously migrating MNs, and the red dashed lines indicate the edge of the explants.\
(D) Quantification of motor axon bundle diameter shows significantly increased numbers of small motor axon fascicles and a decrease of larger motor axon fascicles in *TAG-1^−/−^; HB9::GFP* explants compared to controls (n = 7--8 experiments per genotype).\
(E) Ventral spinal cord explants from E11.5 *HB9::GFP* embryos were cultured on either control substrate or recombinant TAG-1(TAG-1-His~10~)-coated substrate and labeled with GFP antibody and Hoechst stain. The dashed box indicates area of magnified inset. Motor axons form more thick fascicles (red arrowhead) on control substrate than on TAG-1. The white arrowheads indicate precociously migrating MNs, and the red dashed lines indicate the edge of the explants.\
(F) Quantification of motor axon bundle diameter from *HB9::GFP* explants shows a shift from midrange diameter (2.5--5 μm) bundles to smaller (0--2.5 μm) bundles when cultured on a TAG-1-coated substrate versus control substrate (n = 7 embryos per genotype).\
Scale bars: 50 μm in (A); 100 μm in (C) and (E); 10 μm in (C) and (E) insets. Error bars indicate SEM.](nihms-1553326-f0005){#F5}

![LMC Motor Axons Misproject through DRGs in *TAG-1^−/−^* Mice\
(A) E11.5 brachial spinal cord transverse sections from *HB9::GFP, TAG-1^+/−^; HB9::GFP* and *TAG-1^−/−^; HB9::GFP* embryos were stained for TUJ1 and Islet1/2. GFP^+^ motor axons in *TAG-1^+/−^; HB9::GFP* and *TAG-1^−/−^; HB9::GFP* mice invade the DRG (arrows) and re-enter the spinal cord at the DREZ (arrowheads).\
(B) Quantification of GFP^+^ motor axon arborization within DRGs shows significant DRG invasion in *TAG-1^+/−^; HB9::GFP* and *TAG-1^−/−^; HB9::GFP* embryos, but not *HB9::GFP* littermates (n = 3--6 embryos per genotype).\
(C) Lateral views of iDISCO-cleared E12.5 *HB9::GFP* and *TAG-1^−/−^; HB9::GFP* embryos at brachial and thoracic level (schematic shows location and orientation; cropped to one-half of spinal cord) show GFP^+^ motor axons projecting through DRGs and re-entering the spinal cord along the rostro-caudal axis in *TAG-1^−/−^; HB9::GFP* mice. The dashed outlines indicate DRGs, and the arrows point to VRs. The arrowheads in *TAG-1^−/−^; HB9::GFP* panel highlight motor axons that project longitudinally in the dorsal spinal cord after re-entering through the DREZ.\
(D) Spinal cord transverse sections taken after DiI injections into DRGs (schematized in F) of E11.5 wild-type and *TAG-1^−/−^* embryos were labeled with antibodies against FoxP1 and Islet1/2. Retrogradely traced neurons are found in the *TAG-1^−/−^*, but not wild-type, spinal cord ventral horn (dashed outline) and are FoxP1^+^.\
(E) Quantification of DiI^+^ neurons in different motor columns of *TAG-1^−/−^* embryos shows that only LMC (both LMCl and LMCm) neurons misproject axons into DRGs (n = 4 embryos).\
(F) Schematic showing DiI injection strategy for retrograde tracing of misprojecting MNs and the observed labeling in wild-type and *TAG-1^−/−^* embryos.\
Scale bars: 50 μm in (A) and (D); 200 μm in (C). Error bars indicate SEM.](nihms-1553326-f0006){#F6}

![TAG-1 Is Required in Motor Neurons to Guide Their Axons Past DRGs\
(A) E11.5 *TAG-1^cKO/cKO^; HB9::GFP* and *Olig2^Cre/+^; TAG-1^cKO/cKO^; HB9::GFP* brachial spinal cord transverse sections were stained for TUJ1 and Islet1/2. GFP^+^ motor axons invade DRGs (arrow) in *Olig2^Cre/+^; TAG-1^cKO/cKO^; HB9::GFP* mice and re-enter the spinal cord at the DREZ (arrowhead).\
(B) Spinal cord sections from E11.5 *Olig2^IRES-Cre/+^; TAG-1^cKO/cKO^; ROSA26^LSL-tdTom/+^; HB9::GFP* embryos were stained with antibodies against Islet1/2 and RFP to amplify tdTomato (tdTom) signal. TdTom^+^/GFP^+^ motor axons invade the DRG (arrows; in single-channel images, green indicates positive, and red indicates negative for that marker).\
(C) Quantification of GFP^+^ motor axon arborization within DRGs shows significant DRG invasion in *Olig2^Cre/+^; TAG-1^cKO/cKO^; HB9::GFP* and *Olig2^IRES-Cre/+^; TAG-1^cKO/cKO^; ROSA26^LSL-tdTom/+^; HB9::GFP* embryos but not *TAG-1^cKO/cKO^; HB9::GFP* mice (n = 4--6 embryos per genotype). The dashed line indicates that *Olig2^IRES-Cre/+^; TAG-1^cKO/cKO^; ROSA26^LSL-tdTom/+^; HB9::GFP* embryos were not littermates of the other two genotypes.\
(D) High-magnification view of GFP^+^ motor axons in DRGs of *Olig2^IRES-Cre/+^; TAG-1^cKO/cKO^; ROSA26^LSL-tdTom/+^; HB9::GFP* embryos. TdTom^−^/GFP^+^ motor axons are found defasciculating from tdTom^+^/GFP^+^ axon bundles (arrowheads; in single-channel images, green indicates positive and red indicates negative for that marker).\
(E) Quantification of motor axon arborization within DRGs of *Olig2^IRES-Cre/+^; TAG-1^cKO/cKO^; ROSA26^LSL-tdTom/+^; HB9::GFP* embryos, broken down by GFP and tdTom labeling, shows that a minor subset of GFP^+^ motor axons are tdTom^−^ (n = 4 embryos).\
Scale bars: 50 μm in (A) and (B); 10 μm in (D). Error bars indicate SEM.](nihms-1553326-f0007){#F7}

###### 

KEY RESOURCES TABLE

  REAGENT or RESOURCE                                                           SOURCE                        IDENTIFIER
  ----------------------------------------------------------------------------- ----------------------------- ------------------------------------------------------------------------------
  Antibodies                                                                                                  
  mouse-anti-Neurofilament (1:200)                                              DHSB                          Cat\#2H3; RRID:AB_531793
  mouse-anti-Islet1/2 (1:200)                                                   DHSB                          Cat\#39.4D5
  mouse-anti-TAG-1 (1:200)                                                      DHSB                          Cat\#4D7; RRID: AB_531775
  goat polyclonal-anti-TAG-1 (1:200)                                            R&D Systems                   Cat\#AF4439; RRID: AB_2044647
  goat-anti-Sox10 (1:200)                                                       Santa Cruz                    Cat\#sc-17342; RRID: AB_2195374
  rabbit-anti-TUJ1 (1:500)                                                      Biolegend                     Cat\#802001; RRID: AB_2313773
  rabbit-anti-TUJ1 (1:1000)                                                     Covance                       Cat\#MrB-435P; RRID: AB_663339
  rabbit-anti-HB9 (1:10000)                                                     gift from Samuel L. Pfaff     [@R61]
  rabbit-anti-Neurofascin (1:2000)                                              kind gift from Peter Brophy   [@R55]
  rabbit-anti-Lhx3 (1:400)                                                      Abcam                         Cat\#ab14555; RRID: AB_301332
  rabbit-anti-FoxP1 (1:500)                                                     Abcam                         Cat\#ab16645; RRID: AB_732428
  rabbit-anti-Olig2 (1:500)                                                     Millipore                     Cat\#AB9610
  rabbit-anti-RFP (1:500)                                                       Rockland                      Cat\#600-401-379; RRID: AB_2209751
  chick-anti-GFP (1:200)                                                        Abcam                         Cat\#ab13970; RRID: AB_300798
  Alexa488-conjugated donkey anti-goat (1:200)                                  Invitrogen                    Cat\#A11055
  Alexa488-conjugated donkey anti-rabbit (1:200)                                Invitrogen                    Cat\#A21206
  Alexa488-conjugated donkey anti-mouse (1:200)                                 Invitrogen                    Cat\#A21202
  Alexa488-conjugated goat anti-chicken (1:200)                                 Invitrogen                    Cat\#A11039
  Alexa594-conjugated donkey anti-goat (1:200)                                  Invitrogen                    Cat\#A11058
  Alexa594-conjugated donkey anti-rabbit (1:200)                                Invitrogen                    Cat\#A21207
  Alexa594-conjugated donkey anti-mouse (1:200)                                 Invitrogen                    Cat\#A21203
  Alexa647-conjugated donkey anti-goat (1:200)                                  Invitrogen                    Cat\#A21447
  Alexa647-conjugated donkey anti-rabbit (1:200)                                Invitrogen                    Cat\#A31573
  Alexa647-conjugated rabbit anti-goat (1:200)                                  Invitrogen                    Cat\#A27018
  Alexa647-conjugated goat anti-chicken (1:200)                                 Invitrogen                    Cat\#A21449
  Alexa555-conjugated goat anti-mouse (1:200)                                   Invitrogen                    Cat\#A28180
  Alexa488-conjugated goat anti-mouse IgM (1:200)                               Invitrogen                    Cat\#A21042
  Alexa488 donkey anti-chicken (1:500)                                          Jackson ImmunoResearch        Cat\#703-545-155; RRID: AB_2340375
  Hoechst 33342 (1:1000)                                                        Invitrogen                    Cat\#H3570
  donkey-anti-goat-HRP (1:2500)                                                 Jackson ImmunoResearch        Cat\#705-035-003; RRID: AB_2340390
  donkey-anti-rabbit-HRP (1:1500)                                               Jackson ImmunoResearch        Cat\#711-005-152; RRID: AB_2340585
  rabbit-anti-Beta Actin (1:200)                                                Novus                         Cat\#NB600-503; RRID:AB_1216153
  Bacterial and Virus Strains                                                                                 
  *TAG-1* Locus                                                                 CHORI                         RP23-69J15
  DH5-alpha                                                                     ThermoFisher                  Cat\#18265017
  Chemicals, Peptides, and Recombinant Proteins                                                               
  recombinant TAG-1 protein (TAG-1-His~10~)                                     R&D Systems                   Cat\#1714-CN; Lot \#:OCX031803A
  poly-D-Lysine (PDL)                                                           Sigma                         Cat\#P6407
  Laminin                                                                       Millipore                     Cat\#CC095
  Bovine Serum Albumin (BSA)                                                    Sigma                         Cat\#A2153
  DiI                                                                           Invitrogen                    Cat\#V22888
  GDNF                                                                          Sigma                         Cat\#SRP3200
  BDNF                                                                          Cell Science                  Cat\#CRB600B
  Critical Commercial Assays                                                                                  
  Prime-It II Random Primer Labeling Kit                                        Agilent                       Cat\#300385
  RNAscope® Intro Pack for Multiplex Fluorescent Reagent Kit- Fixed Frozen-Rn   ACD Bio-techne                Cat\#323134
  Viofectin                                                                     Viogene                       Cat\#VFT1001
  BCA protein assay                                                             Pierce                        Cat\#23335
  Experimental Models: Cell Lines                                                                             
  COS-7 Cell line                                                               ATCC                          Cat\# CRL-1651
  Experimental Models: Organisms/Strains                                                                      
  mouse: *TAG-1^cKO/cKO^*                                                       this article                  N/A
  mouse: *TAG-1^−/−^*: Cntn2^tm1Furl^                                           [@R46]                        MGI: 2677610
  mouse: *E2A::Cre*: Tg(EIIa-cre)C5379Lmgd                                      [@R30]                        MGI: 2137691
  mouse: *Olig2^Cre^* : Olig2^tm1(cre)Tmj^                                      [@R10]                        MGI: 3774124
  mouse: *Olig2^IRES-Cre^*: Olig2^tm1.1(cre)Wdr^                                [@R75]                        MGI: 4461156
  mouse: *HB9::GFP*: Tg(Hlxb9-GFP)1Tmj                                          [@R69]                        MGI: 3056906
  mouse: *ROSA26^LSL-tdTom^*: Gt(ROSA)26Sor^tm9(CAG-tdTomato)Hze^               [@R37]                        MGI: 3809523
  mouse: *Sema6A^−/−^* : Sema6a^Gt(KST069)Byg^                                  [@R35]                        MGI: 2156202
  mouse: *Nrp2^cKO/cKO^* : Nrp2^tm1.1Mom^                                       [@R65]                        MGI: 3712029
  mouse: *Nrp1^cKO/cKO^*: Nrp1^tm2Ddg^                                          [@R18]                        MGI: 3512101
  mouse: *PlexinA3^−/−^*: Plxna3^tm1Matl^                                       [@R8]                         MGI: 2386961
  mouse: *PlexinA4^−/−^* : Plxna4^tm1Matl^                                      [@R74]                        MGI: 3579185
  mouse: *FLPeR* : Gt(ROSA)26Sor^tm1(FLP1)Dym^                                  [@R11]                        MGI: 2429412
  Oligonucleotides                                                                                            
  Mm-Egr2 probe                                                                 ACD Bio-techne                Cat\#407871
  Recombinant DNA                                                                                             
  pCAGGs-Cntn2                                                                  This article                  N/A
  Software and Algorithms                                                                                     
  Prism 7 for Mac OS X                                                          Graphpad                      <https://download.cnet.com/GraphPad-Prism/3000-2053_4-8453.html>
  ImageJ                                                                        NIH                           <https://imagej.nih.gov/ij/>
  Illustrator CC                                                                Adobe                         <https://www.adobe.com/jp/products/illustrator.html>
  Photoshop CC                                                                  Adobe                         <https://www.adobe.com/products/photoshop.html>
  NIS Elements                                                                  Nikon                         <https://www.microscope.healthcare.nikon.com/products/software/nis-elements>
  Imaris                                                                        Oxford Instruments            <https://imaris.oxinst.com/downloads>

###### Highlights

-   TAG-1 expression during motor neuron development shifts from cell bodies to axons

-   TAG-1 is required to anchor motor neuron cell bodies in the central nervous system

-   Motor axons fail to fasciculate and exhibit guidance defects in *TAG-1^−/−^* mice

-   TAG-1 fulfills its multiple functions independently of one another
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